Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Common Equity (2016 - 2025)

Historic Common Equity for Apyx Medical (APYX) over the last 16 years, with Q3 2025 value amounting to $6.1 million.

  • Apyx Medical's Common Equity fell 4569.97% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year decrease of 4569.97%. This contributed to the annual value of $14.3 million for FY2024, which is 4675.36% down from last year.
  • Apyx Medical's Common Equity amounted to $6.1 million in Q3 2025, which was down 4569.97% from $7.5 million recorded in Q2 2025.
  • Apyx Medical's 5-year Common Equity high stood at $60.2 million for Q1 2021, and its period low was $6.1 million during Q3 2025.
  • For the 5-year period, Apyx Medical's Common Equity averaged around $32.7 million, with its median value being $36.2 million (2023).
  • In the last 5 years, Apyx Medical's Common Equity tumbled by 1369.62% in 2021 and then crashed by 6666.17% in 2024.
  • Apyx Medical's Common Equity (Quarter) stood at $54.0 million in 2021, then tumbled by 30.02% to $37.8 million in 2022, then dropped by 28.76% to $26.9 million in 2023, then plummeted by 46.75% to $14.3 million in 2024, then plummeted by 57.59% to $6.1 million in 2025.
  • Its Common Equity was $6.1 million in Q3 2025, compared to $7.5 million in Q2 2025 and $10.6 million in Q1 2025.